The Written (Worlwide TAVI Experience) Survey

Letter from Dr. José Armando Mangione, President of SOLACI.

Dear Colleagues,

We kindly request you to take part in our survey about cotemporary TAVI practices in Latin American (LATAM) centers. It has been developed for the WRITTEN study, which assessed TAVI practices in 250 centers around the world (29 in LATAM) between March and September 2015. The aim of this new study is to assess the evolution of TAVI in our environment during the last 4 years. We assure you it is fast and will take you no longer tan 10 to 15 minutes. All data will remain confidential. To answer the survey please access by clicking the link below. On the start page, you will be asked to create a new account to be able to answer the questions.

Should you have any questions, please write to writtenlatam2019@gmail.com

We appreciate your invaluable help to better know the state of TAVI practices in LATAM.

Answer the Survey HERE

Kind regards,

Dr. Jose Armando Mangione MD, PhD
President of SOLACI.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. Dr....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...